TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2023

Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects.

Junyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.